Literature DB >> 7796132

Short and long-term changes in dopamine and serotonin receptor binding sites in amphetamine-sensitized rats: a quantitative autoradiographic study.

N Bonhomme1, M Cador, L Stinus, M Le Moal, U Spampinato.   

Abstract

The biochemical changes in DA and 5HT systems were investigated in amphetamine (AMPH)-sensitized rats, 1 and 15 days after cessation of treatment (5 mg/kg AMPH, i.p., twice a day for 6 days). At both times, AMPH-treated rats exhibited behavioral sensitization, as revealed by an enhancement of the stereotypic response to a challenge dose of 2 mg/Kg, ip. AMPH. Basal dopamine (DA) and serotonin (5-HT) metabolism was not significantly modified in different brain areas of AMPH-sensitized rats. Quantitative autoradiographic analysis of DA and serotonin 5-HT receptor subtypes was performed in the following brain regions: medial prefrontal cortex, nucleus accumbens, striatum, substantia nigra, ventral tegmental area, dorsal and median raphe nuclei. A significant increase of [3H]SCH 23390 binding to D1 DA receptors was observed in the substantia nigra pars reticulata 1 day but not 15 days after the cessation of AMPH treatment, whereas [3H]8-OH-DPAT binding to 5-HT1A sites was found to be significantly enhanced in the dorsal raphe nucleus at both time points. No change in D2 DA nor in 5-HT1B or 5-HT2A receptors was found in any of the brain structures examined at either time point. The obtained results suggest that DA and 5-HT systems are differently and time-dependently involved in AMPH-induced behavioral sensitization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796132     DOI: 10.1016/0006-8993(95)00067-z

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  5-Hydroxytryptamine 4(a) receptor expressed in Sf9 cells is palmitoylated in an agonist-dependent manner.

Authors:  E G Ponimaskin; M F Schmidt; M Heine; U Bickmeyer; D W Richter
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

2.  Amphetamine up-regulates activator of G-protein signaling 1 mRNA and protein levels in rat frontal cortex: the role of dopamine and glucocorticoid receptors.

Authors:  M Schwendt; J F McGinty
Journal:  Neuroscience       Date:  2010-03-15       Impact factor: 3.590

3.  Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene.

Authors:  Maryvonne Le Saux; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2005-03       Impact factor: 6.186

4.  Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study.

Authors:  V S Mattay; K F Berman; J L Ostrem; G Esposito; J D Van Horn; L B Bigelow; D R Weinberger
Journal:  J Neurosci       Date:  1996-08-01       Impact factor: 6.167

5.  Influence of chronic amphetamine treatment and acute withdrawal on serotonin synthesis and clearance mechanisms in the rat ventral hippocampus.

Authors:  Jeffrey L Barr; Jamie L Scholl; Rajeshwari R Solanki; Michael J Watt; Christopher A Lowry; Kenneth J Renner; Gina L Forster
Journal:  Eur J Neurosci       Date:  2012-11-14       Impact factor: 3.386

6.  Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brain.

Authors:  Abesh K Bhattacharjee; Lisa Chang; Mei Chen; Laura White; Jane M Bell; Richard P Bazinet; Stanley I Rapoport
Journal:  Int J Neuropsychopharmacol       Date:  2008-06-23       Impact factor: 5.176

7.  Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: effects of pre-treatment with Ro 41-1049.

Authors:  Kirsten E Culver; Henry Szechtman; Beth Levant
Journal:  Eur J Pharmacol       Date:  2008-07-04       Impact factor: 4.432

8.  Histamine H3 receptor antagonist JNJ-39220675 modulates locomotor responses but not place conditioning by dopaminergic drugs.

Authors:  Jenni Vanhanen; Marja Kinnunen; Saara Nuutinen; Pertti Panula
Journal:  Psychopharmacology (Berl)       Date:  2014-10-12       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.